UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000011408
Receipt number R000013346
Scientific Title Efficacy of pranlukast for nasal symptoms and physical activity in asthma children with moderate/severe allergic rhinitis
Date of disclosure of the study information 2013/09/01
Last modified on 2013/08/07 16:50:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of pranlukast for nasal symptoms and physical activity in asthma children with moderate/severe allergic rhinitis

Acronym

Pranlukast for rhinitis and physical activity in children

Scientific Title

Efficacy of pranlukast for nasal symptoms and physical activity in asthma children with moderate/severe allergic rhinitis

Scientific Title:Acronym

Pranlukast for rhinitis and physical activity in children

Region

Japan


Condition

Condition

allergic rhinitis

Classification by specialty

Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Allergic rhinitis is the most prevalent co-morbid disorder in children with asthma. It is a major risk factor for onset and exacerbation of asthma and bothersome symptoms such as nasal obstruction impair quality of life in children. We have observed that physical activity in boys with allergic rhinitis was significantly lower than healthy counterparts. A leukotriene receptor antagonist, pranlukast, has been reported to be effective in ameliorating symptoms of asthma and allergic rhinitis and in improving quality of life of the patients. The aim of the study is to investigate whether pranlukast is efficacious for not only nasal symptoms but also for physical activity in asthma children with moderate/severe asthma.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

symptom score of allergic rhinitis

Key secondary outcomes

physical activity evaluated by using an accelerometer, Lifecorder EX


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

leukotriene receptor antagonist, pranlukast

Interventions/Control_2

antihistamine, fexofenadine

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

7 years-old <=

Age-upper limit

11 years-old >=

Gender

Male

Key inclusion criteria

Eligible patients fulfill the following conditions;
1) House dust mite-sensitized perennial allergic rhinitis with moderate/severe symptom of nasal obstruction based on Practical guideline for the management of allergic rhinitis in Japan 2013
2) Well-controlled bronchial asthma

Key exclusion criteria

1) leukotriene receptor antagonists within 2 weeks before study entry
2) antihistamines within 2 weeks before study entry
3) nasal corticosteroids and/or nasal antihistamines within 2 weeks before study entry
4) systemic corticosteroids within 4 weeks before study entry
5) chronic diseases other than allergy
6) disability or dysfunction of physical activity
7) patients whom a study physician considers inappropriate for the study

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takao Fujisawa

Organization

Mie National Hospital

Division name

Department of Clinical Research

Zip code


Address

357 Osato-kubota, Tsu, Mie, Japan

TEL

059-232-2531

Email



Public contact

Name of contact person

1st name
Middle name
Last name Mizuho Nagao

Organization

Mie National Hospital

Division name

Department of Clinical Research

Zip code


Address

357 Osato-kubota, Tsu, Mie, Japan

TEL

059-232-2531

Homepage URL


Email

nagaomizuho@mie-m.hosp.go.jp


Sponsor or person

Institute

Mie National Hospital

Institute

Department

Personal name



Funding Source

Organization

Japan Allergy Foundation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立病院機構三重病院(三重県)


Other administrative information

Date of disclosure of the study information

2013 Year 09 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2013 Year 08 Month 07 Day

Date of IRB


Anticipated trial start date

2013 Year 09 Month 09 Day

Last follow-up date

2014 Year 12 Month 31 Day

Date of closure to data entry

2015 Year 02 Month 28 Day

Date trial data considered complete

2015 Year 03 Month 31 Day

Date analysis concluded

2015 Year 06 Month 30 Day


Other

Other related information



Management information

Registered date

2013 Year 08 Month 07 Day

Last modified on

2013 Year 08 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013346


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name